Real Brands Announces Entry to Medical Psychedelics Market, Partners with Marcu & Arora for Licensure, R&D
March 24, 2022 08:01 ET | Real Brands Inc.
Real Brands applying for DEA psychedelics licensurePsychedelics drugs market size is projected to reach $10.75 billion by 2027Real Brands planning to leverage new clinical research to produce and...
Canada takes first step toward much-needed regulatory action to address plastic pollution TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Environmental groups applaud Canada's decision today to list “plastic manufactured items” on Schedule 1 under the Canadian Environmental Protection Act...
Le Canada franchit une première étape vers une réglementation indispensable pour lutter contre la pollution plastique TORONTO, 12 mai 2021 (GLOBE NEWSWIRE) -- Les groupes de défense de l’environnement saluent la décision du gouvernement canadien d’ajouter les « articles manufacturés en plastique » à l’Annexe 1 de...
MedTainer logo.jpg
MedTainer Announces Re-Positioning; Level of Industry Interest Increases
March 04, 2019 08:30 ET | MedTainer Inc.
CORONA, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced that the company has begun to re-position in order to attract new and diverse levels of investment and...
MedTainer logo.jpg
MedTainer’s Record-Setting Pace Continues, Plans for Expansion Proceed
March 01, 2019 08:30 ET | MedTainer Inc.
CORONA, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that orders for its signature product, the MedTainer™, have continued to rise and the company has...
MedTainer logo.jpg
Letter to Shareholders from Curt Fairbrother, CEO The Medtainer™
February 19, 2019 08:30 ET | MedTainer Inc.
CORONA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dear Shareholders- I know that you haven’t heard from us in a while, and I apologize for that. I assure you that it was not by omission but by...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing Gum
May 02, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company’s product...
PharmaCyte Biotech's
PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research
June 18, 2015 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - June 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) announced this week that the Company is able to advance its Cannabis research now that its research partner, The...